Olosca Eye Drops (Olopatadine Hydrochloride)
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Os Korea Pharmaceutical Co., Ltd.
MFDS item code 201908063 · Approved 2019.11.25
This product's status changed to Expired on 2024.11.25. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of symptoms of allergic conjunctivitis
This medication is used to relieve symptoms such as itching, redness, and tearing of the eyes caused by allergic conjunctivitis. This drug reduces allergic reactions and improves patient discomfort.
Instill 1 drop twice daily (every 6 to 8 hours). Treatment may continue for up to 4 months if necessary.
This medication should not be used by patients with allergic reactions to the active ingredient or any of its components. Using this medication may cause neurological symptoms such as headaches, taste abnormalities, or dizziness. Rarely, various eye-related symptoms such as punctate keratitis, eye pain, dryness, and redness may occur. Dryness of the nose, allergic rhinitis, oral dryness, or contact dermatitis may also develop. Some patients may feel tired after using this medication. This medication may increase sensitivity in the eyes, and systemic symptoms such as weakness, nausea, and pharyngitis may rarely occur. Increased tear production has also been reported. Because this drug contains phosphates, there is a very rare risk of corneal calcification in patients with severe corneal damage. Although this is a non-sedating antihistamine, it may temporarily cause blurred vision after use, so patients should wait until their vision clears before driving or operating machinery. Patients receiving steroid treatment should gradually reduce the steroid dosage under medical supervision when using this medication. Patients with seasonal allergies are advised to start using this medication before symptoms begin and to continue using it during the symptom period. If there is no effect, long-term use should be avoided, and contact lens wearers should wait at least 15 minutes after using this medication before wearing lenses. It is advisable to avoid wearing lenses when the eyes are red. When using this medication in conjunction with other eye drops, at least 5 minutes should elapse between applications, and ointments should be used last. In pregnant patients, the effects of this medication on the fetus have not been adequately studied, so it should be used cautiously under a doctor’s discretion. In nursing mothers, this medication may be excreted in breast milk, so it should be used after consulting with a physician for the safety of both the mother and the baby. Safety and efficacy have not been established for children under 3 years of age. Elderly patients can use it without specific dose adjustments. In case of overdose, immediately inform medical personnel and receive proper monitoring and treatment. This medication is for eye use only and should not be used as an injection or taken orally. Care should be taken to avoid direct contact of the container tip with the eye, and the cap must always be closed after use. Store in a cool place out of reach of children and avoid direct sunlight. Do not transfer to another container.
Hypersensitivity (severe allergic reaction), liver dysfunction, jaundice, difficulty urinating
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that does not let light in. Additionally, it is preferable to store the medicine at room temperature between 4 and 25 degrees Celsius. This helps maintain the drug's effectiveness for a longer period.
A colorless to light yellow liquid in an opaque white plastic container, used as eye drops.
6 milliliters per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Os Korea Pharmaceutical Co., Ltd.
Olopatadine Hydrochloride 1.11mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.
Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Korea Kyowa Kirin Co., Ltd.
Olopatadine Hydrochloride 2.22mg
Eye drops · Prescription medication
Novartis Korea Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Olopatadine Hydrochloride 5mg
Tablet · Prescription medication
International Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.